Blume Capital Management, Inc. Ionis Pharmaceuticals Inc Transaction History
Blume Capital Management, Inc.
- $432 Million
- Q3 2024
A detailed history of Blume Capital Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Blume Capital Management, Inc. holds 55 shares of IONS stock, worth $1,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 55
-0.0%
Holding current value
$1,840
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
403Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$504 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$474 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$345 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$292 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$263 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.75B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...